Phreesia, Inc. (NYSE:PHR) Shares Acquired by Deutsche Bank AG

Deutsche Bank AG boosted its holdings in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 95.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 57,297 shares of the company's stock after buying an additional 28,047 shares during the quarter. Deutsche Bank AG owned 0.10% of Phreesia worth $1,442,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of PHR. Invesco Ltd. raised its holdings in shares of Phreesia by 0.9% during the fourth quarter. Invesco Ltd. now owns 40,249 shares of the company's stock worth $1,013,000 after purchasing an additional 357 shares during the last quarter. NewEdge Advisors LLC raised its stake in shares of Phreesia by 12.1% during the 4th quarter. NewEdge Advisors LLC now owns 4,256 shares of the company's stock valued at $107,000 after buying an additional 459 shares during the last quarter. Johnson Financial Group Inc. lifted its holdings in shares of Phreesia by 381.3% in the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock valued at $28,000 after buying an additional 896 shares during the period. R Squared Ltd purchased a new stake in shares of Phreesia in the fourth quarter worth about $30,000. Finally, BankPlus Trust Department purchased a new stake in shares of Phreesia in the fourth quarter worth about $34,000. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts recently weighed in on PHR shares. Wall Street Zen cut Phreesia from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Canaccord Genuity Group lowered their target price on shares of Phreesia from $35.00 to $34.00 and set a "buy" rating on the stock in a research note on Thursday. Truist Financial raised their target price on Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a research report on Thursday. KeyCorp reduced their price target on Phreesia from $30.00 to $28.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. Finally, Piper Sandler reiterated an "overweight" rating and set a $33.00 price target (up previously from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. One research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, Phreesia has a consensus rating of "Moderate Buy" and an average price target of $31.33.

Phreesia Price Performance

Shares of Phreesia stock traded up $1.17 during trading hours on Thursday, reaching $24.47. 1,037,651 shares of the company's stock were exchanged, compared to its average volume of 446,791. The business has a fifty day moving average of $24.87 and a two-hundred day moving average of $25.24. The company has a market capitalization of $1.45 billion, a P/E ratio of -16.65 and a beta of 0.74. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $30.53.

Phreesia (NYSE:PHR - Get Free Report) last released its earnings results on Wednesday, May 28th. The company reported ($0.07) earnings per share for the quarter, topping analysts' consensus estimates of ($0.13) by $0.06. The business had revenue of $115.94 million for the quarter, compared to analyst estimates of $115.00 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business's revenue was up 14.5% on a year-over-year basis. During the same period last year, the company posted ($0.05) EPS. As a group, research analysts predict that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, SVP David Linetsky sold 3,944 shares of the stock in a transaction that occurred on Tuesday, April 8th. The shares were sold at an average price of $23.85, for a total value of $94,064.40. Following the completion of the sale, the senior vice president now owns 221,738 shares of the company's stock, valued at $5,288,451.30. This represents a 1.75% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Yvonne Hui sold 1,878 shares of the company's stock in a transaction that occurred on Tuesday, April 8th. The shares were sold at an average price of $23.85, for a total value of $44,790.30. Following the completion of the transaction, the insider now owns 28,449 shares in the company, valued at $678,508.65. This represents a 6.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 42,474 shares of company stock valued at $1,023,208. Insiders own 5.50% of the company's stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.